ALEXANDRIA, Egypt: Growth factor-containing products have long been studied as a way to enhance osseointegration. Researchers at Alexandria University have undertaken a randomised clinical trial of the efficacy of a third-generation platelet concentrate, concentrated growth factor (CGF), in comparison with a second-generation one, platelet-rich fibrin (PRF), in enhancing osseointegration around immediately placed dental implants. They measured implant stability, peri-implant bone density and horizontal bone dimensions, offering crucial insights into the optimisation of implant treatment.